Research & News
New studies, trial results, publications and industry news. 40 discussions in this community. Create a free account to ask a question or share your experience.
Discussions in Research & News
- Bryan Johnson reveals autoimmune stomach condition from extreme longevity regimen - 1 points, 0 comments
- PE 22-28 TREK-1 blocker – what do we really know so far? - 1 points, 0 comments
- Apigenin and CD38 inhibition for NAD preservation - 2 points, 0 comments
- Dulaglutide’s latest cardiovascular data – what it means for off‑label use - 2 points, 0 comments
- What Should You Consider Before You Buy Tesamorelin 10mg? - 4 points, 3 comments
- PE 22-28 and the speed of neuroplasticity vs SSRIs - 4 points, 4 comments
- Testosterone esters and the blood viscosity debate - 4 points, 4 comments
- PE 22-28 and the TREK-1 channel blockade research - 5 points, 0 comments
- R-Alpha Lipoic Acid injectables for metabolic support - 6 points, 4 comments
- ACE-031 development halted over vascular side effects, worth revisiting? - 4 points, 5 comments
- Larazotide zonulin antagonist research, anyone here actually tried it for gut permeability - 6 points, 4 comments
- P21 CNTF-derived peptide for neurogenesis, anyone following the BDNF angle - 3 points, 4 comments
- GlyNAC glutathione restoration study in older adults, anyone here actually run it long term - 6 points, 6 comments
- Matrixyl 45% wrinkle reduction claim, is that from real data or marketing spin - 6 points, 4 comments
- Chonluten lung bioregulator, anyone actually tried it for respiratory support - 4 points, 4 comments
- Dihexa 10 million times more potent than BDNF claim, is that actually meaningful or just marketing - 8 points, 6 comments
- TB4-Frag vs full TB-500, is the fragment actually better for tendon recovery or just marketing - 8 points, 4 comments
- PE 22-28 TREK-1 blocker, anyone following the preclinical antidepressant angle - 3 points, 3 comments
- Dulaglutide REWIND trial cardiovascular data, anyone here tracking GLP-1s for longevity not just weight - 7 points, 3 comments
- Elastin peptides flying under the radar vs collagen, anyone actually tried oral hydrolyzed elastin - 3 points, 4 comments
- PE 22-28 TREK-1 blocker, anyone following the preclinical antidepressant research - 5 points, 4 comments
- Acetyl Hexapeptide-8 for expression wrinkles, is the hype real or just cosmetic wishful thinking? - 7 points, 4 comments
- ARA-290 page on ResearchSafe – thoughts on the innate repair receptor peptide - 5 points, 4 comments
- LSD-assisted therapy trials at 100-200 mcg, is the clinical framework actually scalable? - 6 points, 4 comments
- B12 injections for endurance recovery, anyone actually noticing a difference - 6 points, 4 comments
- PE 22-28 TREK-1 blocker, anyone following the preclinical antidepressant research - 5 points, 4 comments
- Looking at PE 22-28 as a fast‑acting antidepressant peptide – thoughts? - 3 points, 4 comments
- TB4 fragment vs full-length TB-500, does the smaller size actually matter? - 6 points, 6 comments
- PE 22-28 TREK-1 blocker, anyone following the preclinical antidepressant research - 4 points, 4 comments
- Pancragen and the Khavinson bioregulator family, anyone actually tracking metabolic markers? - 6 points, 4 comments
- PE 22-28 and the TREK-1 blockade angle, anyone seen any new preclinical movement - 6 points, 4 comments
- Recent mouse data on PE 22-28 TREK-1 blocker – thoughts - 3 points, 8 comments
- PE 22-28 TREK-1 blocker, is the antidepressant angle real or just rodent hype? - 6 points, 5 comments
- PE 22-28 TREK-1 peptide for depression, anyone following the preclinical stuff - 5 points, 4 comments
- PE 22-28 TREK-1 blocker, anyone following the preclinical antidepressant angle? - 4 points, 5 comments
- Ayahuasca and treatment-resistant depression research, anyone following this? - 8 points, 4 comments
- TB4-Frag vs full TB-500, is the fragment approach actually better? - 5 points, 6 comments
- Klotho protein research, is the cognitive angle getting oversold? - 5 points, 3 comments
- PE 22-28 and TREK-1 blockade, is anyone else watching this space? - 2 points, 6 comments
- Larazotide moving beyond celiac into broader gut permeability research, anyone tracking this? - 7 points, 9 comments
Related compounds
- BPC-157 - Body Protection Compound-157
- TB-500 - Thymosin Beta-4 (Synthetic)
- Pentosan Polysulfate - Pentosan Polysulfate Sodium
- KPV - Lysine-Proline-Valine Tripeptide
- Thymosin Beta-4 - Thymosin Beta-4 (Full Length)
- LL-37 - Cathelicidin Antimicrobial Peptide LL-37
- AOD-9604 - Advanced Obesity Drug Fragment 176-191 (Modified)
- Semaglutide - Semaglutide (GLP-1 Receptor Agonist)
Community discussion - research and educational context only. Not medical advice.